Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Totelle 1mg for Menopausal Symptoms
NCT00195520Phase 4Completed
- Sponsor
- Pfizer
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of estradiol + norgestimate, sponsored by Pfizer. Primary endpoints: Tolerability, Bleeding patterns and 1 more. Started Dec 2004; status: completed.
02
Drugs
estradiol + norgestimate
Beyond the preview
Go deeper on NCT00195520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195520.